BCG therapy given as an adjuvant to surgery: prevention of death from metastases from mammary adenocarcinoma in rats
Sparks, F.C.; O'Connell, T.X.; Lee, Y.T.; Breeding, J.H.
Journal of the National Cancer Institute 53(6): 1825-1826
1974
ISSN/ISBN: 0027-8874 PMID: 4474413 Document Number: 76576
Document emailed within 1 workday
Related Documents
Corbett, T.H.; Griswold, D.P.; Roberts, B.J.; Peckham, J.C.; Schabel, F.M. 1978: Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy Cancer Treatment Reports 62(10): 1471-1488Komatsumoto, M.; Li, S.; Hamada, J.; Takeichi, N.; Hosokawa, M.; Okayasu, T.; Tanabe, T.; Kobayashi, H. 1988: Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(5): 1739-1745
Ashley, M.P.; Zbar, B.; Hunter, J.T.; Rapp, H.J.; Sugimoto, T. 1980: Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery Cancer Research 40(11): 4197-4203
Vasnetsova, S.S.; Kulik, G.I.; Korol', V.I.; Turkevich, N.M. 1977: Hormonal sensitivity of mammary adenocarcinoma in rats and the capacity of the sulfhydryl groups of this tumor for bindig by various antineoplastic drugs Voprosy Onkologii 23(5): 91-94
Tepel, J.; March, C.; Ketterer, T.; Kapischke, M.; Arlt, A.; Kremer, B.; Kalthoff, H.; Kruse, M-Luise. 2006: A modified random oligonucleotide-based combination therapy for adjuvant treatment of pancreatic ductal adenocarcinoma International Journal of Oncology 28(5): 1105-1112
Lorenz, M.; Staib-Sebler, E.; Rossion, I.; Koch, B.; Gog, C.; Encke, A. 1995: Results of resection and adjuvant therapy of liver metastases of primary colorectal tumors--a review of the literature Zentralblatt für Chirurgie 120(10): 769-779
Tsuchiya, T.; Hiramatsu, K.; Tanaka, H.; Machiki, Y.; Sakuragawa, T.; Otsuji, H.; Hara, T.; Kimura, A.; Yoshida, K.; Hosoya, J.; Kojima, T.; Kato, K. 2009: A Case of gastric endocrine cell carcinoma successfully treated by FU plus irinotecan(CPT-11)adjuvant therapy against recurrent metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2641-2644
Sibiriak, S.V.; Lazareva, D.N.; Khaĭbullina, S.F. 1988: Immunomodulating therapy of adjuvant disease in rats Farmakologiia i Toksikologiia 51(2): 72-74
Kubatka, P.; Kalická, K.; Chamilová, M.; Ahlersová, E.; Ahlers, I.; Bojková, B.; Adámeková, E. 2002: Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats Neoplasma 49(4): 255-259
Stoica, G.; Koestner, A.; O'Leary, M. 1985: Characteristics of normal rat mammary epithelial cells and N-ethyl-N-nitrosourea-induced mammary adenocarcinoma cells grown in culture Anticancer Research 5(5): 499-509
Hashimoto, K.; Akahagi, E.; Saito, Y.; Sato, H.; Suda, H. 1978: Evaluation of adjuvant therapy for lung cancer surgery Nihon Kyobu Geka Gakkai 26(3): 330-331
Nagasawa, H.; Yanai, R.; Taniguchi, H. 1976: Importance of mammary gland DNA synthesis on carcinogen-induced mammary tumorigenesis in rats Cancer Research 36(7 Part 1): 2223-2226
Zhang, X.; Malejka-Giganti, D. 2003: Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas Anticancer Research 23(3b): 2473-2479
Nagasawa, H.; Yanai, R. 1974: Frequency of mammary cell division in relation to age: its significance in the induction of mammary tumors by carcinogen in rats Journal of the National Cancer Institute 52(2): 609-610
Dent, D.M.; Hacking, E.A.; Gudgeon, C.A. 1989: Adjuvant therapy after surgery for breast cancer--should women without axillary node involvement be candidates South African Medical Journal 75(11): 513-514
Funatsu, H. 1978: Surgery and adjuvant therapy of lung cancer--with special reference to indications and effects of radiotherapy Nihon Kyobu Geka Gakkai 26(3): 331-334
Diel, I.J. 1991: Current possibilities in the therapy and prevention of bone metastases in breast carcinoma? Zentralblatt für Gynakologie 113(19): 1023-1024
Watanabe, H. 1971: Mammary cancer. 3. Therapy (extensive radical surgery with removal of the parasternal lymph nodes) Kyobu Geka. Japanese Journal of Thoracic Surgery 24(11): 778-783
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Bahena, J.; Labastida Almendaro, S.; Ayala Hernández, J.R.; Fernández Orozco, A. 1998: Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy Ginecologia y Obstetricia de Mexico 66: 87-91